Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis

Clinical and Experimental Immunology

Volumn 139, Issue 2, 2005, Pages 189-201

  Chen, Lin ^a   Martinez, O ^a   Venkataramani, P ^a   Lin, S X ^a   Prabhakar, B S ^a   Chan, Lawrence S ^a,b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal model; Antigen presenting cells; Atopic dermatitis; Proliferation; T cells

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; CONCANAVALIN A; HERMES ANTIGEN; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATORY CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOID ORGAN; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL PROLIFERATION; DERMATITIS, ATOPIC; FLOW CYTOMETRY; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; SKIN; T-LYMPHOCYTES;

EID: 13544256255     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02691.x     Document Type: Article

References (43)

1. Cooper KD. Atopic dermatitis, recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102:128-37.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-60.
3. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94:870-6.
4. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98:225-31.
5. Braathen LR, Forre O, Natvig JB, Eeg-Larsen T. Predominance of T lymphocytes in the dermal infiltrate of atopic dermatitis. Br J Dermatol 1979; 100:511-9.
6. Leung DY, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983; 71:47-56.
7. Zachary CB, Allen MH, MacDonald DM. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 1985; 112:149-56.
8. Lugovic L, Lipozenocic J, Jakic-Razumovic J. Atopic dermatitis: immunophenotyping of inflammatory cells in skin lesions. Int J Dermato 2001; 1:489-94.
9. Woodward AL, Spergel JM, Alenius H. et al. An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammad-elta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis. J Allergy Clin Immunol 2001; 107:359-66.
10. Mihm MC Jr, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976; 67:305-12.
11. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117:977-83.
12. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:44-7.
13. Lee F, Yokota T, Otsuka T. et al. Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell-and mast-cell-stimulating activities. Proc Natl Acad Sci USA 1986; A83:2061-5.
14. Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS, Chan LS. Early upregulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004; 138:375-87.
15. Lever WF, Schaumberg-Lever G. Histopathology of the Skin, 6th Edn. Philadelphia: J.B. Lippincott Co, 1983:99.
16. Elbe-Burger A, Egyed A, Olt S, Klubal R, Mann U, Rappersberger K, Rot A, Stingl G. Overexpression of IL-4 alters the homeostasis in the skin. J Invest Dermatol 2002; 118:767-78.
17. Braathen LR. T-cell subsets in patients with mild and severe atopic dermatitis. Acta Derm Venereol (Suppl)(Stockh) 1985; 114:133-6.
18. Chambers CA. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001; 22:217-23.
19. Venkataramani P, Grzeszkiewicz T, Lin SX, Prabhakar BS, Chan LS. An animal model of atopic dermatitis: lesional skin immunophenotyping delineates a CD4+ T cell-predominated inflammatory infiltrate associated with up-regulation of adhesion molecule. J Invest Dermatol 2003; 121:Abstract no. 44.
20. Campbell DE, Kemp AS. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis. Clin Exp Immunol 1997; 107:392-7.
21. Davison S, Allen M, Vaughan R, Barker J. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000; 121:181-6.
22. Yudate T, Yamada H, Tezuka T. Role of staphylococcal enterotoxins in pathogenesis of atopic dermatitis, growth and expression of T cell receptor V beta of peripheral blood mononuclear cells stimulated by enterotoxins A and B. J Dermatol Sci 1996; 13:63-70.
23. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol 1999; 52:189-96.
24. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10:423-8.
25. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54:271-335.
26. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7:213-21.
27. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecule to signaling regulators. Nat Rev Mol Cell Biol 2003; 4:33-45.
28. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16:201-23.
29. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994; 12:456-65.
30. Marzio R, Mauel J, Betz-Corradin S. CD69 and the regulation of the immune function. Immunopharmacol Immunotoxicol 1999; 21:565-82.
31. Carreno BM, Collins M. The B7 family of ligands and its receptors, new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20:29-53.
32. Latchman Y, Wood CR, Chernova T. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature Immunol 2001; 2:261-8.
33. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, Freeman GJ, Sharpe AH. ICOS is critical for CD40-mediated antibody class switching. Nature 2001; 409:102-5.
34. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Korczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999; 397:263-6.
35. Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNGalpha. Immunity 1999; 11:423-32.
36. Yoshinaga SK, Whoriskey JS, Khare SD. et al T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402:827-32.
37. Gonzalo JA, Tian J, Delaney T. et al. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nature Immunol 2001; 2:597-604.
38. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-I, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11:3887-95.
39. Freeman GJ, Long AJ, Iwai Y. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192:1027-34.
40. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Med 1999; 5:1365-9.
41. Tseng SY, Otsuji M, Gorski K. et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001; 193:839-46.
42. Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel HW. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991; 86:444-8.
43. Mak TW, Penninger JM, Ohashi PS. Knockout mice: a paradigm shift in moderm immunology. Nature Rev Immunol 2001; 1:11-9.